Thomas H. Carter

4.5k total citations · 1 hit paper
34 papers, 1.7k citations indexed

About

Thomas H. Carter is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Thomas H. Carter has authored 34 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Hematology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Thomas H. Carter's work include Acute Myeloid Leukemia Research (8 papers), BRCA gene mutations in cancer (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Thomas H. Carter is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), BRCA gene mutations in cancer (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Thomas H. Carter collaborates with scholars based in United States, United Kingdom and Australia. Thomas H. Carter's co-authors include Morris W. Foster, Sebastian Schwind, Kati Maharry, Maria R. Baer, Krzysztof Mrózek, Susan P. Whitman, Michael D. Radmacher, Bayard L. Powell, Richard A. Larson and Heiko Becker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Thomas H. Carter

34 papers receiving 1.6k citations

Hit Papers

IDH1 and IDH2 Gene Mutations Identify Novel Molecular Sub... 2010 2026 2015 2020 2010 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
    2010 548 citations Guido Marcucci, Kati Maharry et al. Journal of Clinical Oncology profile →

Peers

Thomas H. Carter
Laura J. Rush United States
Richard A. Wells Canada
Robert J. Drummond United States
David R. Betts Switzerland
A.G. Baikie Australia
Martin Hildebrandt Germany
Katherine Smith United States
Faith Kung United States
Sandra K. Masur United States
Stuart J. Swiedler United States
Laura J. Rush United States
Thomas H. Carter
Citations per year, relative to Thomas H. Carter Thomas H. Carter (= 1×) peers Laura J. Rush

Countries citing papers authored by Thomas H. Carter

Since Specialization
Citations

This map shows the geographic impact of Thomas H. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas H. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas H. Carter more than expected).

Fields of papers citing papers by Thomas H. Carter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas H. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas H. Carter. The network helps show where Thomas H. Carter may publish in the future.

Co-authorship network of co-authors of Thomas H. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas H. Carter. A scholar is included among the top collaborators of Thomas H. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas H. Carter. Thomas H. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Katopodis, Periklis, Vladimir Anikin, Uday Kishore, et al.. (2021). Circulating tumour cells and circulating cell-free DNA in patients with lung cancer: a comparison between thoracotomy and video-assisted thoracoscopic surgery. BMJ Open Respiratory Research. 8(1). e000917–e000917. 3 indexed citations
2.
Carter, Thomas H., Nathan M. D’Cunha, Ekavi Georgousopoulou, et al.. (2020). Assessing the diet quality of individuals with rheumatic conditions: a cross-sectional study. Rheumatology International. 40(9). 1439–1448. 2 indexed citations
3.
Carter, Thomas H., et al.. (2014). Smartphone and medical applications use by contemporary surgical trainees: A national questionnaire study. 3(2). 2–10. 5 indexed citations
4.
Schimmer, Aaron D., Azra Raza, Thomas H. Carter, et al.. (2014). A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia. PLoS ONE. 9(10). e108694–e108694. 67 indexed citations
5.
6.
7.
Stallard, Paul, Neil Simpson, Sue Anderson, et al.. (2005). An evaluation of the FRIENDS programme: a cognitive behaviour therapy intervention to promote emotional resilience. Archives of Disease in Childhood. 90(10). 1016–1019. 77 indexed citations
8.
Carter, Thomas H., et al.. (2005). Pilot Study of Lovastatin in Patients with Myelodysplastic Syndrome (MDS) Receiving Arsenic Trioxide (Trisenox®) Therapy.. Blood. 106(11). 4928–4928. 2 indexed citations
9.
Hiatt, Brian, Lucy E. DesJardin, Thomas H. Carter, et al.. (2003). A Fatal Case of West Nile Virus Infection in a Bone Marrow Transplant Recipient. Clinical Infectious Diseases. 37(9). e129–e131. 26 indexed citations
10.
11.
Foster, Morris W., et al.. (1999). The Role of Community Review in Evaluating the Risks of Human Genetic Variation Research. The American Journal of Human Genetics. 64(6). 1719–1727. 74 indexed citations
12.
Foster, Morris W., et al.. (1998). A Model Agreement for Genetic Research in Socially Identifiable Populations. The American Journal of Human Genetics. 63(3). 696–702. 76 indexed citations
13.
Foster, Morris W., et al.. (1997). Genetic Screening of Targeted Subpopulations: The Role of Communal Discourse in Evaluating Sociocultural Implications. Genetic Testing. 1(4). 269–274. 14 indexed citations
14.
Foster, Morris W., et al.. (1997). Communal discourse as a supplement to informed consent for genetic research. Nature Genetics. 17(3). 277–279. 42 indexed citations
15.
Carter, Thomas H., Natalia Domínguez, Liang Zeng, & H J Kung. (1995). Resistance to Transformation by Insertionally Activated c-erbB Is a Dominant Phenotype in Fibroblasts. Virology. 212(1). 277–283. 3 indexed citations
16.
Carter, Thomas H. & Hsing‐Jien Kung. (1994). Tissue-Specific Transformation by Oncogenic Mutants of Epidermal Growth Factor Receptor. Critical Reviews™ in Oncogenesis. 5(4). 389–428. 36 indexed citations
17.
James, Calvin & Thomas H. Carter. (1992). Activation of protein kinase C inhibits adenovirus VA gene transcription in vitro. Journal of General Virology. 73(12). 3133–3139. 4 indexed citations
18.
Kung, H J, Cornelius F. Boerkoel, & Thomas H. Carter. (1991). Retroviral Mutagenesis of Cellular Oncogenes: A Review with Insights into the Mechanisms of Insertional Activation. Current topics in microbiology and immunology. 171. 1–25. 97 indexed citations
19.
Zimmerman, Jay A. & Thomas H. Carter. (1989). Altered Cellular Responses to Chemical Carcinogens in Aged Animals. Journal of Gerontology. 44(6). 19–24. 11 indexed citations
20.
Carter, Thomas H. & Charles G. Miller. (1984). Aspartate-specific peptidases in Salmonella typhimurium: mutants deficient in peptidase E. Journal of Bacteriology. 159(2). 453–459. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura J. Rush Breakdown of academic impact, for papers by Richard A. Wells Breakdown of academic impact, for papers by Robert J. Drummond Breakdown of academic impact, for papers by David R. Betts Breakdown of academic impact, for papers by A.G. Baikie Breakdown of academic impact, for papers by Martin Hildebrandt Breakdown of academic impact, for papers by Katherine Smith Breakdown of academic impact, for papers by Faith Kung Breakdown of academic impact, for papers by Sandra K. Masur Breakdown of academic impact, for papers by Stuart J. Swiedler
Rankless by CCL
2026